Skip to main content
. 2017 Oct 23;131(2):174–181. doi: 10.1182/blood-2017-07-793984

Table 2.

Results according to treatment arm in 319 assessable patients

Result R-CHOP (n = 159) R-CHOP + RT (n = 160)
No. % No. %
After cycle 4
 CR 137 86 144 90
 PR (PET-positive) 22 14 16 10
End of treatment
 CR 150 94 157 98
 PR 8 2
 Progression 0 1
 Relapse 13 8 10 6
 Secondary malignancy 2 2
 Death 12 8 9 6